AiPharma forms alliance with Appili Therapeutics
5th October 2021 Uncategorised 0Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Therapeutics Inc (Appili), to advance the global development of Avigan®/Reeqonus™ (favipiravir). More: AiPharma forms alliance with Appili Therapeutics Source: News
read more